TAMIFLU
HOFFMANN-LA ROCHE LIMITED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TAMIFLU in Canada?
A shortage of TAMIFLU 6MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 25, 2026), but it has not started yet.
Why is TAMIFLU not available?
The reason the manufacturer reported: Demand increase for the drug.
When will TAMIFLU be available again?
The manufacturer's estimated resolution date is December 1, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
OSELTAMIVIR POWDER FOR ORAL SUSPENSION
STRIDES PHARMA CANADA INC
Other Products
TAMIFLU ORAL SUSPENSION
HOFFMANN-LA ROCHE LIMITED
TAMIFLU
HOFFMANN-LA ROCHE LIMITED
MINT-OSELTAMIVIR
MINT PHARMACEUTICALS INC
ACH-OSELTAMIVIR PHOSPHATE
ACCORD HEALTHCARE INC
AG-OSELTAMIVIR
ANGITA PHARMA INC.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02381842
Strength
6MG
Dosage Form
POWDER FOR SUSPENSION
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Demand increase for the drug.
Demand increase for the drug.
Other Products from HOFFMANN-LA ROCHE LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
162MG · DIN 02424770
162MG · DIN 02483327
200MG · DIN 02350106
400MG · DIN 02350114
80MG · DIN 02350092
DIN 02147440
DIN 02225689
150MG · DIN 02458136
25MG · DIN 02270994
2MG · DIN 02245859
200MG · DIN 02242145
250MG · DIN 02192748